文献速递腹部MR

钆塞酸增强MRI肝胆期定性与定量参数预测结直肠癌肝转移术前系统治疗病理反应

Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
PubMed 文献 · Eur J Radiol · 2022-10-28

本研究纳入96例结直肠癌肝转移患者共263个病灶,分析治疗前钆塞酸增强MRI肝胆期的强化模式及信号强度参数。结果显示相对肿瘤强化(RTE)和信号强度标准差比值(SDR)在病理强反应组显著更高,两者联合预测强反应的AUC为0.750,优于RECIST 1.1的0.531。

要点

  • 治疗前肝胆期RTE和SDR越高,结直肠癌肝转移对系统治疗的病理反应越好。
  • RTE联合SDR预测病理强反应的AUC为0.750,优于RECIST 1.1的0.531。
  • 病理强反应定义为残留肿瘤≤10%(PRG2+PRG3),弱反应为>10%(PRG1)。

关键影像表现/征象

  • 肝胆期强化模式和强化程度由两名放射科医师评估。
  • 记录平扫及肝胆期病灶直径、信号强度均值和标准差,计算RTE和SDR。
  • 强反应组(PRG2+PRG3,残留肿瘤≤10%)的RTE和SDR值显著高于弱反应组(PRG1,残留肿瘤>10%)(P<0.001)。

诊断标准与关键数值

  • 病理强反应包括PRG2和PRG3,残留肿瘤≤10%;弱反应为PRG1,残留肿瘤>10%。
  • RTE预测强反应的AUC为0.725,SDR为0.652,两者联合为0.750。
  • RTE(P<0.001)和SDR(P=0.031)是预测强反应的独立因素。
  • 联合参数AUC 0.750优于RECIST 1.1的0.531(P<0.001)。

临床应用与阅片要点

  • 阅片时可关注肝胆期病灶的相对强化程度和信号强度标准差比值,辅助预测系统治疗病理反应。
  • RTE和SDR联合指标可能优于传统RECIST 1.1评估,但需结合临床综合判断。

局限性

  • 回顾性研究,可能存在选择偏倚。
  • 单中心研究,样本量有限(96例患者,263个病灶)。
  • 原文未报告RTE和SDR的具体阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore the value of parameters of the on hepatobiliary phase (HBP) of pre-treatment gadoxetic acid-enhanced magnetic resonance imaging (MRI) for predicting pathological response to systemic therapy in colorectal liver metastases (CRLMs), compared with response evaluation criteria in solid tumors, version 1.1 (RECIST 1.1).

METHODS: A total of 96 patients with CRLMs who underwent gadoxetic acid-enhanced MRI prior to treatment and then liver resection from January 2017 to December 2021 were enrolled. The pathological response was assessed by the percentage of residual tumors (RTs), and CRLMs were classified into two groups according to the pathological response grade (PRG): (1) strong response (including PRG2 and PRG3, RTs ≤ 10%), and weak response (PRG1, RTs > 10%). Two radiologists evaluated the enhancement pattern and degree of CRLMs on the HBP. The diameter, mean and standard deviation (SD) value of signal intensity (SI) of CRLMs on pre-contrast and HBP images were recorded. Relative tumor enhancement (RTE) and the SD ratio (SDR) were calculated. These parameters were analyzed in terms of pathological response on a lesion-by-lesion basis.

RESULTS: Totally, 263 CRLMs were classified into: the strong response group (PRG2, n = 57; PRG3, n = 7) and the weak response group (PRG1, n = 199). RTE and SDR values were significantly higher in the strong response group than in the weak response group (P < 0.001). RTE values (P < 0.001) and SDR values (P = 0.031) were independent factors for predicting strong response. The area under curve (AUC) of RTE and SDR values were 0.725 and 0.652, respectively. The combination of these parameters was 0.750, which performed better than RECIST 1.1 (0.750 vs 0.531; P < 0.001).

CONCLUSIONS: RTE and SDR values on HBP are potential features in predicting pathological response to systemic therapy in CRLMs.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Gu, Cui, Wang, et al. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases. Eur J Radiol. 2022. PMID: 36327859. doi:10.1016/j.ejrad.2022.110572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。